Pieris Pharmaceuticals



Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way.

Ahmed Mousa
SVP, Corporate Operations and General Counsel
Christine Rothe
Vice President, Head of Discovery & Alliance Management
Eckhard Niemeier
Vice President, Head of Business Development
Frank Vollmering
Vice President, Human Resources
Hitto Kaufmann
Senior Vice President and Chief Scientific Officer
Ingmar Bruns
SVP, Head of Clinical Development
Mary Fitzgerald
Vice President of Respiratory Medicine
Shane Olwill
Vice President, Head of Development & Immuno-Oncology
Tom Bures
Vice President, Finance

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.